Clinical Trial Update: Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the pharmacokinetics, safety, and tolerability of ZONISADE in children aged 1 month to 17 years with partial-onset seizures; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• ZONISADE

Snippet

Sponsor: Azurity Pharmaceuticals | Conditions: Seizures, Seizures, Focal | Phase 4 | Status: NOT_YET_RECRUITING